![](/img/cover-not-exists.png)
A Phase II study of estramustine, docetaxel, and carboplatin with granulocyte–colony-stimulating factor support in patients with hormone-refractory prostate carcinoma : Cancer and Leukemia Group B 99813
William K. Oh, Susan Halabi, W. Kevin Kelly, Cary Werner, Paul A. Godley, Nicholas J. Vogelzang, Eric J. Small, for the Cancer, Leukemia Group BVolume:
98
Year:
2003
Language:
english
Pages:
7
DOI:
10.1002/cncr.11829
File:
PDF, 98 KB
english, 2003